Condition: Glioblastoma · Gliosarcoma · Sponsor: Memorial Sloan Kettering Cancer Center
The researchers are doing this study to find out whether the drugs ABBV-637 and ABBV-155 are safe treatments that cause few or mild side effects when given alone or in combination with ERAS-801 in people with recurrent GBM.
This description comes directly from the study's public registry record.
Thomas Kaley, MD · 212-639-5122 · kaleyt@mskcc.org
Ingo Mellinghoff, MD · 646-888-2766
Always discuss trial participation with your own doctor first.
| University of California, Los Angeles (Data Collection Only) | Los Angeles, California, United States | Recruiting |
| University of Miami (Data collection only) | Miami, Florida, United States | Recruiting |
| Indiana University (Data Collection Only) | Indianapolis, Indiana, United States | Recruiting |
| Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) | Basking Ridge, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | Middletown, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) | Commack, New York, United States | Recruiting |
| Memorial Sloan Kettering Westchester (All Protocol Activities) | Harrison, New York, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York, New York, United States | Recruiting |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Rockville Centre, New York, United States | Recruiting |
| University of Vermont Medical Center | Burlington, Vermont, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06934889